Anika Therapeutics Inc (NASDAQ:ANIK)

39.62
Delayed Data
As of Apr 17
 -1.07 / -2.63%
Today’s Change
34.16
Today|||52-Week Range
51.40
-2.75%
Year-to-Date
No recent news for Anika Therapeutics Inc.

Today’s Trading

Previous close40.69
Today’s open40.27
Day’s range39.50 - 40.28
Volume160,253
Average volume (3 months)150,829
Market cap$576.3M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+80.58%
Earnings growth (this year)-45.22%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+40.64%
P/E ratio15.8
Price/Sales5.66
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
OCULOcular Therapeutix I...-1.37-4.94%
NVCNNeovasc Inc+0.10+1.14%
ANGOAngioDynamics Inc-0.25-1.48%
ATRCAtriCure Inc+0.05+0.23%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateApril 28, 2015
EPS forecast (this quarter)$0.21
Annual revenue (last year)$105.6M
Annual profit (last year)$38.3M
Net profit margin36.29%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Charles H. Sherwood
Chief Operating Officer
Francesco J. Luppino
Corporate headquarters
Bedford, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers